TickerFactsScreenerDevelopers

Skye Bioscience, Inc. (SKYE) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2012: $4.3K2013: $182.2K2014: $801.9K2015: $3.04M2016: $1.77M2017: $1.36M2018: $17.52M2019: $1.45M2020: $2.22M2021: $3.99M2022: $12.12M2023: $14.07M2024: $4.61M2025: $8.29M$8.29M
2012Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$8.29M+79.7%
2024$4.61M-67.2%
2023$14.07M+16.1%
2022$12.12M+203.7%
2021$3.99M+79.7%
2020$2.22M+53.3%
2019$1.45M-91.7%
2018$17.52M+1190.8%
2017$1.36M-23.5%
2016$1.77M-41.6%
2015$3.04M+279.1%
2014$801.9K+340.2%
2013$182.2K+4111.6%
2012$4.3K—